{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:31Z","timestamp":1755216751569,"version":"3.43.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:p>Severe congenital neutropenia is an inherited bone marrow failure disorder characterized by profoundly low neutrophil counts and promyelocytic maturation arrest in bone marrow. Severe congenital neutropenia is most often caused by heterozygous <jats:italic toggle=\"yes\">ELANE<\/jats:italic> mutations. In vitro and mouse xenograft studies using CRISPR\/Cas9 have shown that introduction of frameshift\/nonsense mutations in mutant <jats:italic toggle=\"yes\">ELANE<\/jats:italic> may restore neutrophil counts, providing a model for gene therapy. Here, we present 2 children with inherited nonsense mutations in <jats:italic toggle=\"yes\">ELANE<\/jats:italic> analogous to those proposed for gene therapy. Their normal peripheral blood neutrophil counts provide support for this approach through human \u201cexperiments of nature.\u201d<\/jats:p>","DOI":"10.1097\/mph.0000000000002908","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T09:13:57Z","timestamp":1719479637000},"page":"e463-e465","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE: Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia"],"prefix":"10.1097","volume":"46","author":[{"given":"Margret","family":"Joos","sequence":"first","affiliation":[{"name":"Dana-Farber and Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy H.","family":"Chang","sequence":"additional","affiliation":[{"name":"Dana-Farber and Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Shimamura","sequence":"additional","affiliation":[{"name":"Dana-Farber and Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Newburger","sequence":"additional","affiliation":[{"name":"Dana-Farber and Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School, Boston"},{"name":"Departments of Pediatrics and of Molecular, Cell and Cancer Biology, UMass Chan Medical School, Worcester, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/bloodadvances.2021005684","article-title":"Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor","volume":"6","author":"Dale","year":"2022","journal-title":"Blood Adv"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg","year":"2010","journal-title":"Br J Haematol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2006-11-057299","article-title":"Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis","volume":"110","author":"Grenda","year":"2007","journal-title":"Blood"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood-2005-11-4689","article-title":"Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response","volume":"108","author":"K\u00f6llner","year":"2006","journal-title":"Blood"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2020.12.015","article-title":"Dissecting ELANE neutropenia pathogenicity by human HSC gene editing","volume":"28","author":"Rao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.stem.2021.04.007","article-title":"Neutrophil elastase: nonsense lost in translation","volume":"28","author":"Horwitz","year":"2021","journal-title":"Cell Stem Cell"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3324\/haematol.2019.221804","article-title":"CRISPR\/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients","volume":"105","author":"Nasri","year":"2020","journal-title":"Haematologica"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/bloodadvances.2019000498","article-title":"Normal peripheral blood neutrophil numbers accompanying ELANE whole gene deletion mutation","volume":"3","author":"Horwitz","year":"2019","journal-title":"Blood Adv"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41409-020-0800-1","article-title":"HSCT may lower leukemia risk in ELANE neutropenia: a before-after study from the French Severe Congenital Neutropenia Registry","volume":"55","author":"Rotulo","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1182\/blood-2015-02-628859","article-title":"Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation","volume":"126","author":"Fioredda","year":"2015","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:05:12Z","timestamp":1754337912000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002908","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"2024-01-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}